Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Healthtrust
Cipla
McKinsey
Teva
Dow
UBS
Federal Trade Commission
Daiichi Sankyo
Colorcon

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,726,124

« Back to Dashboard

Summary for Patent: 6,726,124
Title: Device for producing high pressure in a fluid in miniature
Abstract:A miniaturized device for pressurizing fluid. The device includes a hollow piston that provides a fluid path and a valve member. The valve member is configured for axial movement so that the valve axis remains parallel to the piston axis. The valve member is arranged at one end of the hollow piston. The valve member may be partially or completely disposed within the hollow piston. The device is particularly adapted for use in a mechanically operated atomizer to produce an inhalable aerosol of a liquid medicament without the use of propellant gas.
Inventor(s): Jaeger; Joachim (Bruchsal, DE), Cirillo; Pasquale (Dortmund, DE), Eicher; Joachim (Dortmund, DE), Geser; Johannes (Dortmund, DE), Freund; Bernhard (Gau-Algesheim, DE), Zierenberg; Bernd (Bingen am Rhein, DE)
Assignee: Boehringer International GmbH (DE)
Application Number:10/292,470
Patent Claim Types:
see list of patent claims
Device;

Drugs Protected by US Patent 6,726,124

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Boehringer Ingelheim COMBIVENT RESPIMAT albuterol sulfate; ipratropium bromide SPRAY, METERED;INHALATION 021747-001 Oct 7, 2011 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Boehringer Ingelheim SPIRIVA RESPIMAT tiotropium bromide SPRAY, METERED;INHALATION 021936-002 Sep 15, 2015 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Boehringer Ingelheim STIOLTO RESPIMAT olodaterol hydrochloride; tiotropium bromide SPRAY, METERED;INHALATION 206756-001 May 21, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Boehringer Ingelheim STRIVERDI RESPIMAT olodaterol hydrochloride SPRAY, METERED;INHALATION 203108-001 Jul 31, 2014 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Boehringer Ingelheim SPIRIVA RESPIMAT tiotropium bromide SPRAY, METERED;INHALATION 021936-001 Sep 24, 2014 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,726,124

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany195 36 902Oct 04, 1995
Germany195 36 902Oct 4, 1995

Non-Orange Book US Patents Family Members for Patent 6,726,124

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,964,416 Device for producing high pressure in a fluid in miniature ➤ Subscribe
7,104,470 Device for producing high pressure in a fluid in miniature ➤ Subscribe
6,402,055 Device for producing high pressure in a fluid in miniature ➤ Subscribe
6,497,373 Device for producing high pressure in a fluid in miniature ➤ Subscribe
6,918,547 Device for producing high pressure in a fluid in miniature ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,726,124

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 003794 ➤ Subscribe
Austria 248028 ➤ Subscribe
Austria 352379 ➤ Subscribe
Australia 7287096 ➤ Subscribe
Australia 730797 ➤ Subscribe
Bulgaria 102345 ➤ Subscribe
Bulgaria 64081 ➤ Subscribe
Brazil 9611140 ➤ Subscribe
Canada 2232151 ➤ Subscribe
Canada 2473681 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
QuintilesIMS
Argus Health
Johnson and Johnson
AstraZeneca
Fuji
Covington
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot